Sat, Feb 28, 2015, 2:59 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Cambridge Heart Inc. Message Board

  • hotstock13 hotstock13 Feb 1, 2012 3:40 PM Flag

    A new idea

    In 1985, Intel was getting killed by Japanese semiconductor companies. Andy Grove and company finally decided something had to change. They literally walked out the door to the street (I read this in a technology magazine in the 1990's after they interviewed Mr. Grove) and turned around and came back in with a new operating philosophy. And that's what started them to develop and make the far more profitable microprocessor. So let's have CAMH management walk out to the street, take a big breath of air, turn around and come back in and change their marketing strategy by selling MTWA to medical payors.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Start with CALPERS

      • 2 Replies to rockenrosco2010
      • I've also talked with people at Medicare (CMS) and they have the same prevailing philosophy as CalPERS: we can't tell doctors what to do. So, the two largest medical payors in the land are reluctant to start-kick MTWA's use. Like many innovations, new ideas have to spring from new, smaller organizations. Blue Cross-Blue Shield of New York is the leader but, so far, there are no followers. It will take time. But CAMH management has to at least TRY to inform them of a technology that can lower their medical bill. As Woody Allen said, "90% of success is just showing up." Look at all those scholarships available to college students that go unused because no one applied for them? Someone out there has to be interested in lowering their medical bill besides BCBS-NY but doesn't know about MTWA. Start knocking CAMH.

      • I've been telling them since 1999, when MTWA finally received FDA approval, that there is a way for them to lower their medical costs. When the CEO's secretary retired around 2005, I asked her what they did with my memos. She said they filed them. I reacted with an astonished look on my face, so she showed me them after her retirement party. They were all there in the file cabinet behind her! So I kept on with the memos (at this point, I was going to badger them to death). Every time I saw something justifying use of MTWA (the Columbia University study noted on Bloomberg, etc.) I sent them on. Finally, their new CEO was more receptive to my ideas and actually passed them on to the medical benefits unit for review. But they dismissed it, saying only one of their three medical providers used MTWA. I countered with why only one was using it and not the others but got no response. Talking with others in their medical benefits unit, I was told the philosophy there is that they can't tell doctors what to do. You have to change the mindset of that whole unit to get that attitude changed. The head of the unit retired but I don't know what their prevailing thought is now because I retired from there. But I sent a link about a shareholder's recent experience with their cardiologist to CalPERS' CEO last week. The only response I have received is an automated note saying she was out of the office for the week. But I can't help feeling there are other public pension funds and American corporations that are more concerned about their rising medical costs. CAMH has to knock on doors to see who's receptive to MTWA's use to lower their medical bill. And when one does it, the rest should follow. Too bad they haven't followed Blue Cross-Blue Shield of New York in telling doctors what tests to use.

 
CAMH
0.00090.0000(0.00%)Feb 27 2:14 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.